Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial
Title:
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial
Author:
Day, Tracey A Penn-Nicholson, Adam Luabeya, Angelique Kany Kany Fiore-Gartland, Andrew Du Plessis, Nelita Loxton, Andre G Vergara, Julie Rolf, Tom A Reid, Tim D Toefy, Asma Shenje, Justin Geldenhuys, Hendrik Tameris, Michele Mabwe, Simbarashe Bilek, Nicole Bekker, Linda-Gail Diacon, Andreas Walzl, Gerhard Ashman, Jill Frevol, Aude Sagawa, Zachary K Lindestam Arlehamn, Cecilia Sette, Alessandro Reed, Steven G Coler, Rhea N Scriba, Thomas J Hatherill, Mark